Tamarly Intelligence
Company · CHRS (NASDAQ - All Markets)

Coherus Oncology, Inc.

Biological Products, (No Diagnostic Substances)

Key figures
Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Institutional holders
147 at 30 Jun 2026 (158 the quarter before) · Who holds it
SEC number
1512762

Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 1 Oct 2026

Questions and answers

Where is Coherus Oncology, Inc. listed?
Coherus Oncology, Inc. trades as CHRS on NASDAQ - All Markets. Tamarly shows no share prices.
How many institutions hold Coherus Oncology, Inc.?
147 institutional holders reported it on SEC Form 13F for the period ended 30 Jun 2026, against 158 the quarter before.
With a free account

A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.

Start freeSign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.

Coherus Oncology, Inc.: CHRS, filings, holders and country risk | Tamarly